Euroscreen Provides Receptor Membranes For GE Healthcare GPCR Products

Euroscreen is to help GE Healthcare, a combination of the former Amersham and GE Medical Systems, service researchers in the drug discovery industry through the supply of receptors to GE Healthcare for SPA GPCR assays.

(PRWEB) October 20, 2004 -- Euroscreen is to help GE Healthcare, a combination of the former Amersham and GE Medical Systems, service researchers in the drug discovery industry through the supply of receptors to GE Healthcare for SPA GPCR assays.

GE Healthcares SPA GPCR assays comprise GE Healthcares SPA beads and ligands along with Eurosceens receptors and a pre-developed assay protocol to allow significant time savings to be achieved in the study of receptor-ligand binding.

Euroscreens supply of receptors to GE Healthcare enables complete GPCR testing needs to be met for researchers and high throughput screeners," said Dr. Pierre Nokin, Euroscreens CEO, We will also continue to sell our own Euroscreen products directly, and strive to provide many assay procedures to customers which will rapidly reduce many difficult assays to essentially shake and bake" simplicity."

In addition, Euroscreen will supply GE Healthcare with receptor membrane preparations for sale in the US, providing a range of relevant GPCR targets for study in the receptor ligand binding field.

For further information, please contact:

Euroscreen s.a.    Pierre Nokin, Ph.D.             

Tel: +32 71 348 500

President and CEO            

pnokin@euroscreen.be

Alfred Gray, Ph.D.             

VP, Business Development        

algray@euroscreen.be

About Euroscreen s.a.

Euroscreen is a world leader in G-protein coupled receptors (GPCRs). The Company integrates its research expertise in this area with its broad product lines of membranes, cell lines and custom screening services for the testing of GPCRs around the world.

The Company also pursues GPCR research programs to develop their patent portfolio of GPCR targets and novel drug leads for licensing to biopharmaceutical companies. To date, Euroscreen has partnered with many companies including CyBio, EvotecOAI, ICOS, Merck & Co, Pfizer Inc, Solvay, Syngenta, UCB and also in-licenses technologies from many institutions and academic centers.

Euroscreen is a privately held company based in Brussels, Belgium currently having 80 employees.

More information can be found at www.euroscreen.be

###